Literature DB >> 17382434

Freezing temperatures in the vaccine cold chain: a systematic literature review.

Dipika M Matthias1, Joanie Robertson, Michelle M Garrison, Sophie Newland, Carib Nelson.   

Abstract

The dangers of accidental freezing of vaccines in the cold chain have prompted studies throughout the globe to better characterize the risk. To date, there has been no systematic review of these studies. This analysis highlights that accidental freezing is pervasive and occurs across all segments of the cold chain. Between 14% and 35% of refrigerators or transport shipments were found to have exposed vaccine to freezing temperatures, while in studies that examined all segments of distribution, between 75% and 100% of the vaccine shipments were exposed. More rigorous study designs were associated with higher levels of freeze exposure. As more expensive, freeze-sensitive vaccines are introduced into immunization schedules, freeze prevention will become increasingly critical for ensuring that the world's children are receiving fully potent vaccine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382434     DOI: 10.1016/j.vaccine.2007.02.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  71 in total

1.  Graphic-output temperature data loggers for monitoring vaccine refrigeration: implications for pertussis.

Authors:  Patrick McColloster; Carlos Vallbona
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

2.  A freeze-stable formulation for DTwP and DTaP vaccines.

Authors:  Honggang Xue; Bangling Yang; Debra D Kristensen; Dexiang Chen
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Authors:  Manoj V Murhekar; Srihari Dutta; Ambujam Nair Kapoor; Sailaja Bitragunta; Raja Dodum; Pramit Ghosh; Karumanagounder Kolanda Swamy; Kalyanranjan Mukhopadhyay; Somorjit Ningombam; Kamlesh Parmar; Devegowda Ravishankar; Balraj Singh; Varsha Singh; Rajesh Sisodiya; Ramaratnam Subramanian; Tana Takum
Journal:  Bull World Health Organ       Date:  2013-09-09       Impact factor: 9.408

Review 4.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

5.  Evaluation of an outside-the-cold-chain vaccine delivery strategy in remote regions of western China.

Authors:  Qian Ren; Hongyan Xiong; Yafei Li; Rufu Xu; Caizhong Zhu
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

6.  Vaccine Presentation and Packaging Advisory Group: a forum for reaching consensus on vaccine product attributes.

Authors:  Osman David Mansoor; Debra Kristensen; Andrew Meek; Simona Zipursky; Olga Popova; Olga Popovaa; InderJit Sharma; Gisele Miranda; Jules Millogo; Heidi Lasher
Journal:  Bull World Health Organ       Date:  2012-11-05       Impact factor: 9.408

7.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.

Authors:  Kimberly J Hassett; David J Vance; Nishant K Jain; Neha Sahni; Lilia A Rabia; Megan C Cousins; Sangeeta Joshi; David B Volkin; C Russell Middaugh; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-01-11       Impact factor: 3.534

8.  Factors affecting vaccine handling and storage practices among immunization service providers in Ibadan, Oyo State, Nigeria.

Authors:  David M Dairo; Oyarebu E Osizimete
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

9.  Validation of the shake test for detecting freeze damage to adsorbed vaccines.

Authors:  Umit Kartoglu; Nejat Kenan Ozgüler; Lara J Wolfson; Wiesław Kurzatkowski
Journal:  Bull World Health Organ       Date:  2010-02-09       Impact factor: 9.408

10.  Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.

Authors:  Kimberly J Hassett; Megan C Cousins; Lilia A Rabia; Chrystal M Chadwick; Joanne M O'Hara; Pradyot Nandi; Robert N Brey; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2013-04-10       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.